These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21487653)

  • 41. Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
    Katzenschlager R; Manson AJ; Evans A; Watt H; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):295-7. PubMed ID: 14742609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.
    Leggio L; Zywiak WH; Fricchione SR; Edwards SM; de la Monte SM; Swift RM; Kenna GA
    Biol Psychiatry; 2014 Nov; 76(9):734-41. PubMed ID: 24775991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
    Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
    Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
    Brunette MF; Akerman SC; Dawson R; O'Keefe CD; Green AI
    Alcohol; 2016 Jun; 53():45-50. PubMed ID: 27256763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial.
    Potvin S; Morin M; Cloutier C; Gendron A; Bissonnette A; Marchand S
    J Clin Psychopharmacol; 2012 Oct; 32(5):684-7. PubMed ID: 22926604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine for the treatment of cocaine use disorder.
    Tapp A; Wood AE; Kennedy A; Sylvers P; Kilzieh N; Saxon AJ
    Drug Alcohol Depend; 2015 Apr; 149():18-24. PubMed ID: 25682480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
    Sheehan DV; Harnett-Sheehan K; Hidalgo RB; Janavs J; McElroy SL; Amado D; Suppes T
    J Affect Disord; 2013 Feb; 145(1):83-94. PubMed ID: 22920718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
    Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.
    Sheehan DV; Svedsäter H; Locklear JC; Eriksson H
    J Affect Disord; 2013 Dec; 151(3):906-13. PubMed ID: 24135509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
    Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
    Weisler RH; Calabrese JR; Thase ME; Arvekvist R; Stening G; Paulsson B; Suppes T
    J Clin Psychiatry; 2008 May; 69(5):769-82. PubMed ID: 18452345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
    Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
    Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open-label pilot study of quetiapine treatment for cannabis dependence.
    Mariani JJ; Pavlicova M; Mamczur AK; Bisaga A; Nunes EV; Levin FR
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):280-4. PubMed ID: 24963729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study.
    Chengappa KN; Parepally H; Brar JS; Mullen J; Shilling A; Goldstein JM
    Can J Psychiatry; 2003 Apr; 48(3):187-94. PubMed ID: 12728743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
    Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
    Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
    Sheehan DV; Locklear J; Svedsäter H; Datto C
    Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.
    Chen YC; Chen CK; Wang LJ
    BMC Psychiatry; 2012 Sep; 12():162. PubMed ID: 23020711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.